CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
My Diabetes Care (MDC)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05448105
NCT05448105N/ACompleted
CompareCT.gov

My Diabetes Care: A Scalability and Usability Study

Vanderbilt University Medical Center·interventional·Posted Jul 7, 2022·Updated Mar 20, 2025

In Brief

A clinical study evaluating My Diabetes Care (MDC) for Diabetes Mellitus, Type 2. Completed, enrolled 67 participants across 2 sites.

Detailed Summary

The purpose of this study is to conduct a prospective, longitudinal study on the My Diabetes Care (MDC) mobile intervention to assess usage patterns, user experience, and to uncover errors in functionality prior to a larger interventional trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 7, 2022
Enrollment StartDec 22, 2022
Primary CompletionJan 9, 2024
Study CompletionFeb 22, 2024
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 4.0 years ago

Interventions

My Diabetes Care (MDC)other

My Diabetes Care (MDC) is a multi-faceted patient portal intervention that is designed to help patients better understand their diabetes health data as well as promote and support self-management. MDC uses infographics to facilitate patients' understanding of their diabetes health data (e.g., HbA1c, LDL) and provides literacy level-appropriate diabetes self-care information. In this study, the MDC user-interface was expanded to display additional diabetes health-data, including urine microalbumin and weight/body mass index (BMI) and a Spanish-language version of MDC was available to Spanish-speaking patients with limited English proficiency.